ArticleThe Journal of international medical research2025
Tunnelless totally implantable venous access device implantation via ultrasound-guided axillary vein puncture: A retrospective analysis.
Article in The Journal of international medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tunnelless totally implantable venous access device implantation via ultrasound-guided axillary vein puncture: A retrospective analysis.The Journal of international medical research · 2025Article
- Ultrasound-guided axillary vein versus internal jugular vein access for totally implantable venous access ports in breast cancer: a retrospective comparison of patient-reported outcomes.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveThis study aimed to assess the feasibility and safety of using the ultrasound-guided axillary vein puncture technique to implant the totally implantable venous access device without a tunnel.MethodsThis study retrospectively analyzed data from 703 patients who underwent totally implantable venous access device implantation in the chest wall between January 2022 and March 2023. Ultimately, 685 patients underwent tunnelless totally implantable venous access device implantation via ultrasound-guided axillary vein puncture. We collected data regarding the patients' age, sex, body weight, body mass index, axillary vein diameter, depth of the axillary vein from the body surface, surgical success rate, operation duration, and postoperative follow-up.ResultsOf the 703 patients who signed the consent forms for totally implantable venous access device implantation, 685 were included in the axillary vein puncture group. The follow-up period ended on 31 August 2023; the mean follow-up duration was 281.59 days. The following complications were observed: catheter retrograde to the internal jugular vein in seven patients, catheter occlusion in three patients, catheter-related infections in two patients, catheter-related vein thrombosis in two patients, and skin infection around the infusion port in one patient. The overall immediate and long-term complication rate was 2.13%.ConclusionThe tunnelless totally implantable venous access device implantation technique via ultrasound-guided axillary vein puncture offers a highly effective, safe, and aesthetically pleasing alternative for chest wall totally implantable venous access device implantation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.